Paul Clancy

Investors who took the advice of the popular slogan "sell in May and go away" may now be wishing they can go back in time and hold on to their positions, especially those that belonged to a small handful of names that soared 50 percent since May, Bloomberg reported. The hottest S&P 500 stock...

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) announced Wednesday the appointment of Paul Clancy as its chief financial officer, effective July 31, though he is expected to join the company on July 10. Previously, Clancy served as the CFO of biotech firm Biogen Inc (NASDAQ: BIIB) for a decade...